27136/34351US=2 / Biol/Mol
Naik E, Strasser A. Bcl-2 family: the role of the Bcl-2 protein family in tumorigenesis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 317-45. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; TUMORIGENESE; CANCER. TERAPIA; MORTE CELULAR; APOPTOSE

27137/34351US=2 / Biol/Mol
Dempsey CE, Roberts DL, Dive C. Bcl-2 family: bax, bak and bid: key mediators of apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 346-78. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; BAX; BAK; BID; MEDIADORES DE APOPTOSE; VIAS MITOCONDRIAIS; CANCER

27138/34351US=1-B / Farmacologia
Flexner C. Antiretroviral agents and treatment of HIV infection. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1273-1314. ISBN 978-0-071-142280-3.

AGENTES DE TRATAMENTO; INFECCAO POR HIV ANTI-RETROVIRAIS; HISTORIA DA TERAPIA ANTI-RETROVIRAL; QUIMIOTERAPIA DO HIV; NUCLEOSIDEOS; INIBIDORES DA TRANSCRIPTASE REVENSE NUCLEOTIDOS; INIBIDORES NAO-NUCLEOSIDEOS DA TRANSCRIPTASE REVERSA; INIBIDORES DA PROTEASE DO HIV; INIBIDORES DE ENTRADA

27139/34351US=2 / Biol/Mol
Erlacher M, Michalak EM, Strasser A, Villunger A. Bcl-2 family: the BH3-only proteins puma and noxa: two brothers in arms. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 379-402. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; PROTEINAS BH3; PUMA; NOXA; REGULACAO DA P53; MORTE CELULAR

27140/34351US=2 / Biol/Mol
Holcik M. IAPs: inhibitor of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 403-26. ISBN 978-3-527-31237-5.

IAPS; INIBIDORES DE PROTEINAS DE APOPTOSE

27141/34351US=2 / Biol/Mol
Altieri DC. IAPs: targeting the survivin pathway for rational cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 427-42. ISBN 978-3-527-31237-5.

IAPS; SURVIVINA; INIBIDOR DE PROTEINA A APOPTOSE

27142/34351US=2 / Biol/Mol
Greten FR, Karin M. Survival pathways: nuclear factor-kB in apoptosis and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 443-61. ISBN 978-3-527-31237-5.

CANCER; FATOR NUCLEAR-KB; APOPTOSE; CARCINOGENESE

27143/34351US=1-B / Farmacologia
Chabner BA, Amrein PC, Druker BJ, Michaelson MD, Mitsiades CS, Doss PE, Ryan DP, Ramachandra S, Richardson PG, Supko JG, Wilson WH. Antineoplastic agents. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1315-1403. ISBN 978-0-071-142280-3.

AGENTES ANTINEOPLASICOS; AGENTES ALQUILANTES; TOXICIDADES DOS AGENTES ALQUILANTES; DIVERSAS DROGAS ALQUILANTES; ANALOGOS DE ACIDO FOLICO; PIRIMIDINA ANALOGOS; ANALOGOS DA CITIDINA; ANALOGOS DE PURINAS; DROGAS ANTIMITOTICAS; ANTIBIOTICOS; EPIPODOFILOTOXINAS; ENZIMAS

27144/34351US=2 / Biol/Mol
Scheid MP, Woodgett JR. Survival pathways: cell survival through phosphoinositide 3-kinase and protein kinase B. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 463-89. ISBN 978-3-527-31237-5.

SOBREVIVENCIA CELULAR; FOSFATIDILINOSITOL 3-QUINASE; PROTEINA QUINASE B; MTOR

27145/34351US=1-B / Farmacologia
Krensky AM, Vinventi F, Bennett WM. Immunosuppressants, tolerogens, and immunostimulants. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1405-1431. ISBN 978-0-071-142280-3.

RESPOSTA IMUNE; IMUNOSSUPRESSORES; TOLEROGENS; IMUNOESTIMULANTES; IMUNOTERAPIA

27146/34351US=2 / Biol/Mol
Drexler HCA, Hekman GM, Albert S, Rapp UR. Survival pathways: survival regulation by ras and raf. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 490-513. ISBN 978-3-527-31237-5.

CONTROLE DE SOBREVIVENCIA; RAS; RAF; APOPTOSE

27147/34351US=1-B / Farmacologia
Kaushansky K, Kipps TJ. Hematopoietic agents: growth factors, minerals, and vitamins. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1433-1465. ISBN 978-0-071-142280-3.

AGENTES HEMATOPOIETICOS; FACTORES DE CRESCIMENTO; MINERAIS; VITAMINAS; ERITROPOIETINAS; FATORES DE CRESCIMENTO MIELOIDES; FATORES DE CRESCIMENTO TROMBOPOIETICO; PIRIDOXINA

27148/34351US=2 / Biol/Mol
Speidel D, Deppert W. Oncogenes/tumor suppressor genes: p53-mediated apoptosis: a multifaceted story. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 515-35. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES DE TUMOR; P53; APOPTOSE MEDIADA

27149/34351US=1-B / Farmacologia
Majeruus PW, Tollefsen DM. Blood coagulantion and anticoagulante, thrombolytic, and antiplatelet drugs. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1433-1465. ISBN 978-0-071-142280-3.

COAGULACAO SANGUINEO; ANTICOAGULANTES; TROMBOLITICOS; ANTIPLAQUETARIOS

27150/34351US=2 / Biol/Mol
Ramadan S, Sayan E, Oberst A, Chikh A, Pietroni V, Rufini A, Melino G, Bernassola F. Oncogenes/tumor suppressor genes: p73 affects cell fate and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 536-50. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES TUMORAIS; P73; TUMORIGENESE

27151/34351US=2 / Biol/Mol
Chau BN, Bergseid J, Wang JYJ. Oncogenes/tumor suppressor genes: RB and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 551-67. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES DE TUMORES; RB; CANCER; APOPTOSE

27152/34351US=1-B / Farmacologia
Parker KL, Schimmer BP. Pituitary hormones and their hypothalamic releasing hormones. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1489-1510. ISBN 978-0-071-142280-3.

HORMONIOS HIPOFISARIOS; HORMONIOS DE LIBERACAO HIPOTALAMICOS; PROLACTINA; LIBERADOR DE GONADOTROFINAS; HORMONIO; HORMONIOS GONADOTROFICOS; OXITOCINA

27153/34351US=1-B / Farmacologia
Farwell AP, Braverman LE. Thyroid and antithyroid drugs. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1511-1540. ISBN 978-0-071-142280-3.

TIROIDE; ANTITIREOIDIANOS; INIBIDORES DA TIROIDE

27154/34351US=1-B / Farmacologia
Loose DS, Stancel GM. Estrogens and progestins. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1541-1571. ISBN 978-0-071-142280-3.

ESTROGENIOS; PROGESTAGENOS; ANTI-PROGESTIS; MODULADORES DE RECEPTORES DE PROGESTERONA; CONTRACEPTIVOS HORMONAIS

27155/34351US=2 / Biol/Mol
Orrenius S, Zhivotovsky B. Modulators: calcium signaling in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 569-95. ISBN 978-3-527-31237-5.

MODULADORES; SINALIZACAO DE CALCIO; APOPTOSE; MORTE CELULAR

Primeira | Anterior | Próxima | Última